Trial · NCT07885254
Testing a Smartphone App to Support a Mediterranean Diet and Strength Exercise
NCT07885254, Not applicable, Not yet recruiting, Liverpool John Moores University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Testing a Smartphone App to Support a Mediterranean Diet and Strength Exercise. Trials, record NCT07885254. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07885254
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Testing a Smartphone App to Support a Mediterranean Diet and Strength Exercise
- NCT number
- NCT07885254
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 30 participants, estimated
- Lead sponsor
- Liverpool John Moores University
- Conditions
- Treatment Adherence and Compliance, Resistance Exercise, Mediterranean Diet, Healthy Volunteers
- Interventions
- MedEx Tracker, Printed dietary and resistance exercise programme
- First posted
- 2026-10-21
- Last updated
- 2026-11-06
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mediterranean diet adherence | Baseline and week 4 | Adherence measured using the 14-item Mediterranean Diet Adherence Screener (MEDAS). Total score ranges from 0 to 14, with higher scores indicating greater adherence |
| Primary | Resistance exercise adherence | Baseline and week 4 | Weekly muscle-strengthening exercise frequency, self-reported using the long form of the Muscle-Strengthening Exercise Questionnaire (MSEQ). Reported in days per week (minimum 0, maximum 7); higher values indicate more frequent muscle-strengthening exercise, i.e. greater adherence. This is a frequency count rather than a scale score; the MSEQ has no composite total score. Total weekly frequency is taken as the highest frequency reported across the four MSEQ exercise types. |
| Primary | Application usability | Week 4 (end of intervention) | Usability assessed in the intervention group using the Mobile App Usability Questionnaire (MAUQ). Higher scores indicate better usability. |
| Primary | Application quality and acceptability | Week 4 (end of intervention) | Assessed in the intervention group using the user version of the Mobile Application Rating Scale (uMARS), scored across engagement, functionality, aesthetics and information quality. Scoring is 1-5 (higher= better). |
| Primary | Engagement with the application | Weeks 1-4, recorded continuously by the application | Frequency of application access and completeness of dietary and resistance training records, derived from application-generated data in the intervention group. |
| Secondary | Dietary intake | Baseline and week 4 | Energy and macronutrient intake derived from three-day food records. |
| Secondary | Body mass | Baseline and week 4 | In kg using calibrated scales |
| Secondary | Body composition | Baseline and week 4 | Fat mass and fat-free mass assessed by bioelectrical impedance analysis |
| Secondary | Recruitment rate | From the start of recruitment to randomisation of the final participant (up to approximately 4 months) | Number of participants randomised per month of recruitment. Also reported: * number screened * proportion of those screened who are eligible * proportion of eligible people who consent and are randomised |
| Secondary | Retention rate | Baseline to week 4 (end of intervention) | Proportion of randomised participants who attend the week-4 follow-up visit, reported overall and by arm, with reasons for withdrawal where given. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07885254
GET https://conductscience.org/api/trials/v1/NCT07885254/registered